Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project

Sameer H Halani, Daniel J Brat

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

A recently published investigation by The Cancer Genome Atlas on lower grade diffuse gliomas provides biologic justification for defining diseases based on genetic properties rather than histologic features. Unsupervised clustering of data from multiple advanced molecular platforms divided diseases robustly into 3 cohesive groups that could be captured by clinically available biomarkers more reliably than by histology.

Original languageEnglish (US)
Pages (from-to)e1074333
JournalMolecular & cellular oncology
Volume3
Issue number2
DOIs
StatePublished - Mar 2016

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project'. Together they form a unique fingerprint.

Cite this